LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Biology of mitral valve prolapse

    Daniele Ronco / Gianpiero Buttiglione / Andrea Garatti / Alessandro Parolari

    Frontiers in Cardiovascular Medicine, Vol

    from general mechanisms to advanced molecular patterns—a narrative review

    2023  Volume 10

    Abstract: Mitral valve prolapse (MVP) represents the most frequent cause of primary mitral regurgitation. For several years, biological mechanisms underlying this condition attracted the attention of investigators, trying to identify the pathways responsible for ... ...

    Abstract Mitral valve prolapse (MVP) represents the most frequent cause of primary mitral regurgitation. For several years, biological mechanisms underlying this condition attracted the attention of investigators, trying to identify the pathways responsible for such a peculiar condition. In the last ten years, cardiovascular research has moved from general biological mechanisms to altered molecular pathways activation. Overexpression of TGF-β signaling, for instance, was shown to play a key role in MVP, while angiotensin-II receptor blockade was found to limit MVP progression by acting on the same signaling pathway. Concerning extracellular matrix organization, the increased valvular interstitial cells density and dysregulated production of catalytic enzymes (matrix metalloproteinases above all) altering the homeostasis between collagen, elastin and proteoglycan components, have been shown to possibly provide a mechanistic basis contributing to the myxomatous MVP phenotype. Moreover, it has been observed that high levels of osteoprotegerin may contribute to the pathogenesis of MVP by increasing collagen deposition in degenerated mitral leaflets. Although MVP is believed to represent the result of multiple genetic pathways alterations, it is important to distinguish between syndromic and non-syndromic conditions. In the first case, such as in Marfan syndrome, the role of specific genes has been clearly identified, while in the latter a progressively increasing number of genetic loci have been thoroughly investigated. Moreover, genomics is gaining more interest as potential disease-causing genes and loci possibly associated with MVP progression and severity have been identified. Animal models could be of help in better understanding the molecular basis of MVP, possibly providing sufficient information to tackle specific mechanisms aimed at slowing down MVP progression, therefore developing non-surgical therapies impacting on the natural history of this condition. Although continuous progress has been made in this field, ...
    Keywords mitral valve prolapse ; mitral regurgitation ; molecular biology ; fibroelastic deficiency ; Barlow disease ; Marfan syndrome ; Diseases of the circulatory (Cardiovascular) system ; RC666-701
    Subject code 570
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Survival and Recurrence of Endocarditis following Mechanical vs. Biological Aortic Valve Replacement for Endocarditis in Patients Aged 40 to 65 Years

    Antonio Salsano / Michele Di Mauro / Laura Labate / Alessandro Della Corte / Federica Lo Presti / Michele De Bonis / Cinzia Trumello / Mauro Rinaldi / Erik Cura Stura / Guglielmo Actis Dato / Giuseppe Punta / Francesco Nicolini / Davide Carino / Carlo De Vincentiis / Andrea Garatti / Giangiuseppe Cappabianca / Andrea Musazzi / Diego Cugola / Maurizio Merlo /
    Davide Pacini / Gianluca Folesani / Sandro Sponga / Igor Vendramin / Alberto Pilozzi Casado / Francesco Rosato / Elisa Mikus / Carlo Savini / Francesco Onorati / Giovanni Battista Luciani / Roberto Scrofani / Francesco Epifani / Francesco Musumeci / Antonio Lio / Andrea Colli / Giosuè Falcetta / Salvatore Nicolardi / Salvatore Zaccaria / Enrico Vizzardi / Antonio Pantaleo / Giuseppe Minniti / Emmanuel Villa / Margherita Dalla Tomba / Francesco Pollari / Fabio Barili / Alessandro Parolari / Roberto Lorusso / Francesco Santini

    Journal of Clinical Medicine, Vol 13, Iss 1, p

    Data from the INFECT-Registry

    2023  Volume 153

    Abstract: Background: Infective endocarditis (IE) is a serious disease, and in many cases, surgery is necessary. Whether the type of prosthesis implanted for aortic valve replacement (AVR) for IE impacts patient survival is a matter of debate. The aim of the ... ...

    Abstract Background: Infective endocarditis (IE) is a serious disease, and in many cases, surgery is necessary. Whether the type of prosthesis implanted for aortic valve replacement (AVR) for IE impacts patient survival is a matter of debate. The aim of the present study is to quantify differences in long-term survival and recurrence of endocarditis AVR for IE according to prosthesis type among patients aged 40 to 65 years. Methods: This was an analysis of the INFECT-REGISTRY. Trends in proportion to the use of mechanical prostheses versus biological ones over time were tested by applying the sieve bootstrapped t-test. Confounders were adjusted using the optimal full-matching propensity score. The difference in overall survival was compared using the Cox model, whereas the differences in recurrence of endocarditis were evaluated using the Gray test. Results: Overall, 4365 patients were diagnosed and operated on for IE from 2000 to 2021. Of these, 549, aged between 40 and 65 years, underwent AVR. A total of 268 (48.8%) received mechanical prostheses, and 281 (51.2%) received biological ones. A significant trend in the reduction of implantation of mechanical vs. biological prostheses was observed during the study period ( p < 0.0001). Long-term survival was significantly higher among patients receiving a mechanical prosthesis than those receiving a biological prosthesis (hazard ratio [HR] 0.546, 95% CI: 0.322–0.926, p = 0.025). Mechanical prostheses were associated with significantly less recurrent endocarditis after AVR than biological prostheses (HR 0.268, 95%CI: 0.077–0.933, p = 0.039). Conclusions: The present analysis of the INFECT-REGISTRY shows increased survival and reduced recurrence of endocarditis after a mechanical aortic valve prosthesis implant for IE in middle-aged patients.
    Keywords endocarditis ; aortic valve replacement ; prosthetic heart valve ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Is fixed severe pulmonary hypertension still a contraindication to heart transplant in the modern era of mechanical circulatory support? A review.

    Andrea, Garatti / Giuseppe, Bruschi / Tiziano, Colombo / Maria, Frigerio / Ettore, Vitali

    Journal of cardiovascular medicine (Hagerstown, Md.)

    2008  Volume 9, Issue 10, Page(s) 1059–1062

    Abstract: Pulmonary vascular hypertension (PVH) is a common complication of severe, long-lasting chronic heart failure. It is nowadays well recognized that PVH, nonresponsive to pharmacological approaches, is a risk factor for early and late mortality after heart ... ...

    Abstract Pulmonary vascular hypertension (PVH) is a common complication of severe, long-lasting chronic heart failure. It is nowadays well recognized that PVH, nonresponsive to pharmacological approaches, is a risk factor for early and late mortality after heart transplant. Recent evidences in literature highlighted that in these patients chronic unloading with left ventricular assist device resulted in significant reduction of pulmonary vascular resistance, thus ultimately leading them to successful heart transplant. We described the case history of a 47-year-old man with ischemic cardiomyopathy who underwent uncomplicated Berlin Heart Incor implant for severe chronic heart failure and fixed PVH. Chronic unloading determined a rapid and dramatic improvement of PVH, and the patient underwent successful heart transplant after 5 months of mechanical support.
    MeSH term(s) Antihypertensive Agents/therapeutic use ; Contraindications ; Cost-Benefit Analysis ; Drug Resistance ; Heart Failure/complications ; Heart Failure/economics ; Heart Failure/physiopathology ; Heart Failure/surgery ; Heart Failure/therapy ; Heart Transplantation/economics ; Heart-Assist Devices/economics ; Hemodynamics ; Humans ; Hypertension, Pulmonary/economics ; Hypertension, Pulmonary/etiology ; Hypertension, Pulmonary/physiopathology ; Hypertension, Pulmonary/therapy ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome ; Ventricular Function
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2008-10
    Publishing country United States
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 2223461-5
    ISSN 1558-2035 ; 1558-2027
    ISSN (online) 1558-2035
    ISSN 1558-2027
    DOI 10.2459/JCM.0b013e3282f64249
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top